APOA5 抗体 (N-Term)
Our Local Distributor
北京 101111
Quick Overview for APOA5 抗体 (N-Term) (ABIN965570)
抗原
See all APOA5 抗体适用
宿主
克隆类型
标记
应用范围
-
-
抗原表位
- N-Term
-
纯化方法
- Purified by antigen-specific affinity chromatography.
-
免疫原
- Polyclonal antibody produced in rabbits immunizing with a synthetic peptide corresponding to N-terminal residues of human APOA5 (Apolipoprotein A-V precursor)
-
-
anti-Apolipoprotein A-V (APOA5) (AA 167-335) antibody
APOA5 适用: 人 WB, IHC, IP, ICC 宿主: 兔 Polyclonal unconjugated
anti-Apolipoprotein A-V (APOA5) (AA 167-335) antibodyAPOA5 适用: 人 WB, IHC, IP, ICC 宿主: 小鼠 Monoclonal C11 unconjugated
anti-Apolipoprotein A-V (APOA5) (AA 21-210) antibodyAPOA5 适用: 小鼠 WB, IHC 宿主: 兔 Polyclonal unconjugated
anti-Apolipoprotein A-V (APOA5) (AA 21-210) antibodyAPOA5 适用: 小鼠 WB, IHC, IP, ICC 宿主: 小鼠 Monoclonal C1 unconjugated
anti-Apolipoprotein A-V (APOA5) antibodyAPOA5 适用: 人 ELISA, ICC 宿主: 小鼠 Monoclonal 2G1H11-HRP-1F1E8 unconjugated
anti-Apolipoprotein A-V (APOA5) antibodyAPOA5 适用: 人, 小鼠, 大鼠 WB, IF (p), IHC (p) 宿主: 兔 Polyclonal unconjugated
anti-Apolipoprotein A-V (APOA5) (AA 207-366) antibodyAPOA5 适用: 人 WB 宿主: 兔 Polyclonal unconjugated
anti-Apolipoprotein A-V (APOA5) (N-Term) antibodyAPOA5 适用: 人 WB, ELISA, ICC, IF 宿主: 兔 Polyclonal unconjugated
anti-Apolipoprotein A-V (APOA5) (AA 1-366) antibodyAPOA5 适用: 人 WB 宿主: 小鼠 Polyclonal unconjugated
anti-Apolipoprotein A-V (APOA5) (AA 169-367) antibodyAPOA5 适用: 大鼠 WB, IHC 宿主: 兔 Polyclonal unconjugated
-
-
应用备注
- ELISA, Western blotting: 1µg/ml for 2hrs.
-
限制
- 仅限研究用
-
-
-
状态
- Liquid
-
缓冲液
- This antibody is stored in PBS, 50% glycerol
-
储存液
- Sodium azide
-
注意事项
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
储存条件
- -20 °C
-
-
- APOA5 (Apolipoprotein A-V (APOA5))
-
别名
- APOA5
-
背景
- APOA5(Apolipoprotein A-V) is a minor apolipoprotein mainly associated with HDL and to a lesser extent with VLDL. APOA5 may also be associated with chylomicrons. APOA5 is an important determinant of plasma triglyceride (TG) levels by both being a potent stimulator of apo-CII lipoprotein lipase (LPL) TG hydrolysis and a inhibitor of the hepatic VLDLTG production rate (without affecting the VLDL-apoB production rate). Three common alleles are known: allele APOA5*1, APOA5*2 and APOA5*3. The APOA5*2 haplotype, which consists of 3 non-coding SNPs, is present in approximately 16% of Caucasians and is associated with increased plasma triglyceride concentrations. APOA5*3 haplotype is defined by the rare Ser-19-Trp substitution. Together, the APOA5*2 and APOA5*3 haplotypes are found in 25 to 50% of African Americans, Hispanics, and Caucasians.
-
途径
- Regulation of Lipid Metabolism by PPARalpha, Lipid Metabolism
抗原
-
